Volitionrx (VNRX) Net Cash Flow Growth (1y) (2012 - 2025)
Volitionrx (VNRX) Net Cash Flow Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 76.43% |
| 10 | Volitionrx | 90,923.30 | -1.03 Mn | - | 119.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 119.55% |
| Sep 30, 2025 | -2,666.07% |
| Jun 30, 2025 | 88.69% |
| Mar 31, 2025 | 92.67% |
| Dec 31, 2024 | -133.70% |
| Sep 30, 2024 | 100.88% |
| Jun 30, 2024 | -161.08% |
| Mar 31, 2024 | -980.75% |
| Dec 31, 2023 | 281.61% |
| Sep 30, 2023 | -2,045.28% |
| Jun 30, 2023 | 233.36% |
| Mar 31, 2023 | -124.71% |
| Dec 31, 2022 | -123.58% |
| Sep 30, 2022 | 91.59% |
| Jun 30, 2022 | -41.96% |
| Mar 31, 2022 | -76.17% |
| Dec 31, 2021 | -46.96% |
| Sep 30, 2021 | -4,367.05% |
| Jun 30, 2021 | -154.55% |
| Mar 31, 2021 | 354.31% |